{
    "id": "a147a04b-630a-4280-9663-fef59cc8fef0",
    "indications": {
        "text": "pravastatin sodium tablets indicated :",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 take orally daily time day , without food ( 2.1 ) . \u2022 patients require high-intensity statin unable achieve ldl-c goal receiving pravastatin sodium tablets 80 mg daily , prescribe alternative ldl-c-lowering treatment ( 2.1 ) . \u2022 assess ldl-c clinically appropriate , early 4 weeks initiating pravastatin sodium , adjust necessary ( 2.1 ) . \u2022 adults : recommended starting pravastatin sodium tablets 40 mg 80 mg daily . ( 2.2 ) \u2022 pediatric patients ( 2.3 ) : \u2022 aged 8 13 years , recommended 20 mg daily . \u2022 aged 14 18 years , recommended starting 40 mg daily . \u2022 severe renal impairment : recommended starting pravastatin sodium 10 mg daily . recommended maximum pravastatin sodium tablets 40 mg daily . ( 2.4 ) \u2022 full prescribing information modifications due ( 2.5 , 7 ) .",
        "doid_entities": [],
        "orphanet_entities": [
            {
                "disease": "severe renal impairment",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_447788"
            }
        ]
    },
    "warningsAndPrecautions": "product : 50090-7551 ndc : 50090-7551-0 30 tablet bottle ndc : 50090-7551-1 90 tablet bottle",
    "adverseReactions": "acute liver failure decompensated cirrhosis [ ( 5.3 ) ] . hypersensitivity pravastatin excipients pravastatin sodium tablets .",
    "ingredients": [
        {
            "name": "PRAVASTATIN SODIUM",
            "code": "3M8608UQ61",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_8361"
        },
        {
            "name": "SILICA",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "HYDROXYPROPYL METHYLCELLULOSE",
            "code": "3NXW29V3WO",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30618"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        },
        {
            "name": "METHYLGLUCAMINE",
            "code": "6HG8UB2MUY",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01828"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        }
    ],
    "organization": "A-S Medication Solutions",
    "name": "Pravastatin Sodium",
    "effectiveTime": "20250528",
    "indications_original": "Pravastatin sodium tablets are indicated:",
    "contraindications_original": "\u2022 Take orally once daily at any time of the day, with or without food ( 2.1 ). \u2022 For patients that require a high-intensity statin or are unable to achieve their LDL-C goal receiving pravastatin sodium tablets 80 mg daily, prescribe alternative LDL-C-lowering treatment ( 2.1 ). \u2022 Assess LDL-C when clinically appropriate, as early as 4 weeks after initiating pravastatin sodium, and adjust the dosage if necessary ( 2.1 ). \u2022 Adults: recommended starting dosage is pravastatin sodium tablets 40 mg to 80 mg once daily. ( 2.2 ) \u2022 Pediatric Patients ( 2.3 ): \u2022 aged 8 to 13 years, the recommended dosage is 20 mg once daily. \u2022 aged 14 to 18 years, the recommended starting dosage is 40 mg once daily. \u2022 Severe renal impairment: recommended starting dosage is pravastatin sodium 10 mg once daily. Recommended maximum pravastatin sodium tablets dosage is 40 mg once daily. ( 2.4 ) \u2022 See full prescribing information for dosage modifications due to drug interactions ( 2.5 , 7 ).",
    "warningsAndPrecautions_original": "Product:    50090-7551\n                  NDC:    50090-7551-0   30 TABLET in a BOTTLE\n                  NDC:    50090-7551-1   90 TABLET in a BOTTLE",
    "adverseReactions_original": "Acute liver failure or decompensated cirrhosis [see Warnings and Precautions (\n                     \n                     \n                        5.3\n                        )\n                     \n                     ].\n                     \n                  \n                  \n                     Hypersensitivity to any pravastatin or any excipients in pravastatin sodium tablets.",
    "drug": [
        {
            "name": "Pravastatin Sodium",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_8361"
        }
    ]
}